Fecal microbiota transplantation from Hezuo pigs alleviates intestinal inflammatory injury in Clostridium perfringens type C-infected piglets via modulation gut microbiota and intestinal barrier Authors: Qiaoli Yang, YuHao Liang, Jing Liu, Rui Jia, Jie Li, ZunQiang Yan Published: 2026 ABSTRACT Clostridium perfringens type C (CpC)-induced piglet diarrhea is a major challenge in the swine industry. This study aimed to investigate the protective effects of fecal microbiota transplantation (FMT) from Hezuo pigs against intestinal injury in Duroc×Landrace×Yorkshire (DLY) suckling piglets infected with CpC. Piglets were divided into two groups, including CpC-challenged control group and FMT-treatment group, which received fecal suspension from Hezuo pigs prior to infection. Morphological, immunological, microbiomic, and metabolomic analyses were conducted after post-infection. The results demonstrated that FMT significantly alleviated jejunal damage, leading to a significant increase in jejunal villus height and a significant decrease in crypt depth (P < 0.01). The intervention elevated the number of goblet cells (P < 0.05) and upregulated the expression of tight junction protein genes Occludin, ZO-1, Claudin-1 and the anti-inflammatory cytokine IL-10, while significantly reducing the levels of pro-inflammatory cytokines TNF-α and IL-6 (P < 0.05). FMT enriched beneficial genera such as Akkermansia, Rothia, Peptococcus, and Proteocatella, and increased the levels of the sphingolipid metabolite ceramide (d18:1/18:0). Correlation analysis further indicated that these microbiota alterations were positively associated with intestinal barrier repair and anti-inflammatory activity, and were strongly correlated with ceramide (d18:1/18:0) levels. In conclusion, FMT mitigates CpC-induced intestinal injury by modulating the gut microbiota and metabolome, thereby enhancing intestinal barrier integrity and regulating inflammatory responses. This study provides theoretical support and practical insights for the application of FMT as a promising microbiome-based strategy to control CpC-associated intestinal diseases in piglets. Introduction Clostridial diarrhea in piglets caused by Clostridium perfringens type C (CpC) poses a major challenge to the global swine industry [1, 2], contributing to substantial economic losses. This disease principally impacts suckling piglets, with the first week of life being the critical window for infection. Clinical manifestations are characterized by rapid onset, short duration, and high rates of morbidity and mortality [3–5]. CpC diarrhea is endemic in many major pig-producing countries, including Switzerland, China, and the United States [6–8]. Despite growing concerns over antimicrobial resistance, drug residues, and environmental impact, current prevention and control strategies for CpC diarrhea in pigs still rely heavily on antibiotic interventions, such as the use of ciprofloxacin, amoxicillin, and oxytetracycline. However, the widespread use of these antibiotics not only accelerates the evolution of drug-resistant strains but also leads to drug residues that may pose threats to the food safety and ecological environment, which is contradictory to the development objectives of sustainable animal husbandry. Consequently, there exists an urgent need to develop sustainable, non-antibiotic alternative strategies for managing CpC infections in pig production. The intestinal microbiota of young animals is highly dynamic and vulnerable to disruption by stressors such as weaning and environmental changes [9, 10]. Dysbiosis can impair immune function, increasing susceptibility to enteric pathogens (such as CpC, Escherichia coli and Salmonella) Fecal microbiota transplantation (FMT) has emerged as a promising approach to restore intestinal barrier function and immune homeostasis by reintroducing a balanced microbial community [11–13]. Originally documented as early as the 4th century in China for treating diarrhea, FMT has gained renewed attention for its applications in veterinary and livestock medicine [14]. FMT holds significant application value in animal husbandry, with groundbreaking progress particularly in improving the intestinal health of piglets. Transplanting fecal microbiota from 90-day-old Duroc × Landrace × Yorkshire (DLY) pigs to 3-day-old DLY piglets can significantly inhibit intestinal inflammatory responses and alleviate the clinical symptoms of porcine deltacoronavirus (PDCoV) infection in piglets via the regulation of the TLR4/MyD88/NF-κB signaling pathway [15]. For suckling piglets infected with Enterotoxigenic Escherichia coli (ETEC), fecal microbiota transplantation from healthy 3-month-old pigs significantly alleviates diarrhea and markedly enriches the jejunal microbiota [16]. Additionally, FMT can enhance inter-breed tolerance to stress-induced diarrhea, as demonstrated in Landrace × Yorkshire (LY) piglets that received transplants from adult Congjiang Xiang pigs [17]. FMT is also beneficial to other livestock species. For instance, it modulates the intestinal microbial composition and enhances growth performance in weaned Bos taurus coreanae calves [18]. For Lingnan Yellow chickens, early FMT yields sustained growth benefits, an effect mediated by the maintenance of jejunal Lactobacillus populations, preservation of jejunal mucosal barrier integrity, and upregulation of growth axis-related gene expression [19]. These cross-species studies collectively underscore the broad potential of FMT as a microbiome-targeting intervention in animal husbandry. Hezuo pigs are a native Tibetan pig breed unique to the high-altitude areas of Gannan Tibetan Autonomous Prefecture, Gansu Province, China. They demonstrate remarkable adaptability to extreme environmental conditions, such as hypoxia and low temperatures [20, 21]. Their diet is mainly composed of local forages including Potentilla anserina and wild alfalfa, supplemented only minimally with highland barley and corn. These unique feeding practices are associated with superior roughage tolerance and disease resistance compared to commercial pig breeds [22]. Our preliminary research on the intestinal microflora composition of Hezuo pigs showed a significant enrichment of bacterial genera with crude fiber-degrading functions, such as the UCG-005 and Prevotella_NK3B31 group [23]. Based on these findings, we hypothesize that traits (such as roughage tolerance and disease resistance) may be closely related to their unique intestinal microflora structure. Furthermore, this distinct intestinal microflora may contribute to enhanced host resistance against CpC infection. To evaluate the protective effects of FMT from Hezuo pigs against intestinal injury in CpC-challenged DLY suckling piglets, we conducted a comprehensive analysis encompassing intestinal histopathology, inflammatory factor expression, gut microbiota composition, and metabolic profiles. Our objective was to elucidate the mechanisms through which FMT confers protection against CpC infection, thereby providing a scientific basis for novel, microbiome-based strategies that support antibiotic reduction. Materials and methods Preparation of CpC bacterial suspension The CpC standard strain C59-2 (CVCC 2032) used in this study was purchased from the China Institute of Veterinary Drug Control (Beijing, China) by previous researchers in our research group [24]. The lyophilized powder of CpC was reconstituted by inoculating it into 5 mL of meat broth medium containing beef granules at 37 °C (Qingdao Hope Bio-Technology Co., Ltd., Qingdao, China), and the resulting bacterial suspension was incubated anaerobically at 37 °C for 16–20 h. After purification by streaking on blood agar plates, single colonies were picked for subculture and preservation. The strain used in this experiment was a subculture of the original stock. First, the strain was inoculated into 300 µL of cooked meat medium and vortexed for complete resuspension. Subsequently, 50 µL of the bacterial suspension was transferred to 5 mL of cooked meat medium containing beef particles, and incubated anaerobically at 37 °C for 16–20 h in an anaerobic culture bag. Then, 10 µL of the culture was subjected to 10-fold serial dilutions (down to 10⁻¹⁰ CFU/mL). Dilutions ranging from 10⁻⁶ CFU/mL to 10⁻¹⁰ CFU/mL were evenly spread-plated onto Tryptose Sulfite Cycloserine (TSC) agar plates supplemented with 0.5% D-cycloserine and 50% egg yolk emulsion (20 mL of each supplement was added per 250 mL of medium). Triplicate plates were prepared for each dilution. After anaerobic incubation at 37 °C for 20–24 h, plates containing 20–200 colonies were counted to calculate the mean value, and the concentration of the original bacterial suspension (CFU/mL) was calculated by multiplying by the corresponding dilution factor. According to previous findings from our research group, the optimal challenge dose of CpC to induce obvious diarrhea in 7-day-old piglets is 1 × 10⁹ CFU/mL [24]. Accordingly, the bacterial suspension was diluted to 1 × 10⁹ CFU/mL and stored sealed at -80 °C. Preparation of fecal suspension Fecal samples were aseptically collected from healthy 6-month-old Hezuo pigs raised under semi-free-range conditions in Hezuo City, Gannan Tibetan Autonomous Prefecture, Gansu Province. Donors had no history of antibiotic treatment within 3 months prior to sampling. Fresh feces were immediately aliquoted into 15 mL sterile centrifuge tubes and flash-frozen in liquid nitrogen. For fecal microbiota suspension preparation, thawed fecal samples were mixed with pre-chilled sterile physiological saline at a ratio of 1:5 (w/v), thoroughly homogenized, and sequentially filtered through sterile sieves to remove large particulate matter. Sterile glycerol was added to a final concentration of 10% (v/v), and the suspension was aliquoted into sterile cryovials and stored at -80 °C. On the day of transplantation, the fecal microbiota suspension was thawed on ice for 2 h and kept chilled on ice throughout the administration process. Animal experiment and sample collection Eight healthy 7-day-old DLY crossbred suckling piglets with similar body weights were selected, initial body weights are presented in Table 1. All piglets were purchased from Zhonghui Co., Ltd., Linxia City, Gansu Province. None of the piglets had been vaccinated, and they were raised antibiotic-free throughout the experiment at the Animal Husbandry Experimental Center of Gansu Agricultural University. The housing environment was managed in accordance with strict disinfection and ventilation protocols, with 2 piglets housed per pen. They were fed a scheduled, quantitative regimen of artificial milk replacer (Anyou Biotechnology Hunan, China) every 2 h following a 2-day adaptation period. After acclimatization, piglets were randomly assigned to two groups (n = 4 per group): the CpC challenged group (C) and the FMT intervention combined with CpC challenged group (FC). From days 1 to 5, piglets in the C and FC groups received daily oral administrations of 2.0 mL sterile saline or fecal suspension, respectively. From days 6 to 10, both groups received 1.0 mL of 1.0 × 10⁹ CFU/mL CpC bacterial solution. Table 1Initial body weight of experimental pigletsPig numberInitial body weight (kg)Average weight of each group (kg)C13.433.41 ± 0.11C23.45C33.52C43.24FC13.593.61 ± 0.26FC23.7FC33.27FC43.91 Table 1Initial body weight of experimental pigletsPig numberInitial body weight (kg)Average weight of each group (kg)C13.433.41 ± 0.11C23.45C33.52C43.24FC13.593.61 ± 0.26FC23.7FC33.27FC43.91 Initial body weight of experimental piglets On day 11, following a 12-hour fast, blood samples were collected from experimental piglets via jugular venipuncture, after which serum and plasma were isolated from the blood samples. The piglets were then subjected to deep anesthesia and humane euthanasia with sodium pentobarbital for subsequent tissue and organ sample collection. Mid-jejunum segments were rinsed with Phosphate Buffered Saline (PBS) and fixed in 4% paraformaldehyde (Servicebio, Hubei, China) for morphological analysis; jejunal contents were divided for gut microbiota and metabolomic sequencing, as well as tight junction protein analysis. All procedures were approved by the Animal Care and Use Ethics Committee of Gansu Agricultural University and conducted in compliance with the Guide for the Care and Use of Laboratory Animals (8th edition). Hematoxylin and eosin (H&E) staining Paraformaldehyde-fixed jejunal tissue was dehydrated in gradient ethanol and xylene, and embedded in paraffin. Section (4 μm thick) were stained with hematoxylin and eosin (H&E), dehydrated, cleared, and mounted [25]. Villi height and crypt depth were measured using Fiji ImageJ 2.9.0 software. Periodic acid-schiff (PAS) staining PAS staining was performed to observe jejunal goblet cells. Sections were dewaxed, hydrated, then treated with periodate oxidation for 10 to 20 min. After distilled water washing, they reacted with Schiff reagent in the dark for 15 to 30 min. Excess dye was removed by running water, followed by hematoxylin re-staining of nuclei and running water rinsing to turn nuclei blue. Finally, gradient ethanol dehydration, xylene transparency, and neutral gum sealing were done [26]. Inflammatory factors contents detection Blood samples were centrifuged at 3000 × g for 10 min to separate serum. Commercial enzyme-linked immunosorbent assay (ELISA) kits (Jiangsu Kete Biotechnology, Jiangsu, China) were used to measure the concentrations of interleukin-6 (IL-6), interleukin-10 (IL-10), tumor necrosis factor α (TNF-α), and interleukin-1β (IL-1β). Each group comprised three biological replicates. Quantitative real-time polymerase chain reaction (qRT-PCR) Total RNA was extracted from jejunum tissue using Trizol reagent (Ecoray Biotech, Hunan, China) according to the manufacturer’s instructions. The cDNA was synthesized using the Evo M-MLV reverse transcription premix kit (Ecoray Biotech, Hunan, China). qRT-PCR was performed using a 20 µL reaction volume consisting of 10 µL of 2 × Universal Blue SYBR Green qPCR Master Mix (Ecoray Biotech, Hunan, China), 0.8 µL each of forward and reverse primers (Table 1), 2 µL cDNA, and 6.4 µL ddH₂O. The amplification program consisted of a pre-denaturation at 95 °C for 30 s, followed by 40 cycles of denaturation at 95 °C for 5 s and annealing at 60 °C for 30 s. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was selected as the reference gene, and relative expression levels were calculated by the 2⁻ΔΔCt method [27]. Table 2List of genes and primer sequence for quantitative real-time PCR analysisGenePrimer sequences (5′ to 3′)Length (bp)Accession no. ZO-1 F: TGAGTTTGATAGTGGCGTTGR: TGGGAGGATGCTGTTGTC298XM_021098827.1 OCLN F: CAGTGGTAACTTGGAGGCGTR: CCGTCGTGTAGTCTGTCTCG104NM_001163647.2 Claudin-1 F: GGACTAATAGCCATCTTTGTR: CAGCCATCCGCATCTTCT88NM_001244539.1 GAPDH F: AGTATGATTCCACCCACGGCR: TACGTAGCACCAGCATCACC139NM_001206359.1 Table 2List of genes and primer sequence for quantitative real-time PCR analysisGenePrimer sequences (5′ to 3′)Length (bp)Accession no. ZO-1 F: TGAGTTTGATAGTGGCGTTGR: TGGGAGGATGCTGTTGTC298XM_021098827.1 OCLN F: CAGTGGTAACTTGGAGGCGTR: CCGTCGTGTAGTCTGTCTCG104NM_001163647.2 Claudin-1 F: GGACTAATAGCCATCTTTGTR: CAGCCATCCGCATCTTCT88NM_001244539.1 GAPDH F: AGTATGATTCCACCCACGGCR: TACGTAGCACCAGCATCACC139NM_001206359.1 List of genes and primer sequence for quantitative real-time PCR analysis F: TGAGTTTGATAGTGGCGTTG R: TGGGAGGATGCTGTTGTC F: CAGTGGTAACTTGGAGGCGT R: CCGTCGTGTAGTCTGTCTCG F: GGACTAATAGCCATCTTTGT R: CAGCCATCCGCATCTTCT F: AGTATGATTCCACCCACGGC R: TACGTAGCACCAGCATCACC 16S rRNA gene sequencing Genomic DNA was extracted from jejunal contents using the MagBeads FastDNA Kit for Soil (MP Biomedicals, California, USA). The V3-V4 region of the bacterial 16S rRNA gene was amplified using primers 338F (5’-ACTCCTACGGGAGGCAGCA-3’) and 806R (5’-GGACTACHVGGGTWTCTAAT-3’). PCR protocol included: 5 min initial denaturation at 98 °C; 25 cycles of denaturation at 98 °C for 30 s, annealing at 52 °C for 30 s, and extension at 72 °C for 45 s; followed by a final extension at 72 °C for 5 min. Amplified products were gel-purified on 2% agarose. Sequencing libraries were prepared using the TruSeq Nano DNA LT Library Prep Kit (Illumina, California, USA), quantified with Qubit 4 fluorometer, and assessed for fragment size distribution using an Agilent 2100 Bioanalyzer. Normalized libraries were pooled and sequenced on an Illumina NovaSeq platform (Illumina, USA) with the NovaSeq 6000 SP Reagent Kit (500 cycles) for paired-end 2 × 250 bp reads. All analyses were conducted by PerSonalbio Biotechnology Co., Ltd. (Shanghai, China). The raw paired-end reads were processed via QIIME2 (v.2024.5). Sequences were demultiplexed via the demux plugin, trimmed of primers with cutadapt, and then subjected to quality-filtering, denoising, merging, and chimera removal using DADA2. Amplicon Sequence Variants (ASVs) were taxonomically annotated against the Greengenes13.8 database with 97% similarity. Alpha diversity metrics (Chao1, Observed species, Shannon, Simpson) and Bray-Curtis-based Principal Coordinate Analysis (PCoA) were conducted. Taxonomic profiles were visualized as pie charts at phylum and genus levels in R (v4.3.3). Community composition differences were tested using PERMANOVA (F-test), while alpha diversity indices were compared via Student’s t-test. Random forest importance analysis was performed with the mlr3 package (bagging algorithm), and differentially abundant taxa were identified via LEfSe (LDA > 3, P < 0.05). Metabolomics sequencing Jejunal contents samples were mixed with pre-cooled methanol (containing 5 ppm 2-chloro-L-phenylalanine) and steel beads, then sequentially vortexed for 30 s, ground twice at 55 Hz (60 s/cycle), sonicated for 10 min, frozen at -20 °C for 30 min, and centrifuged at 12,000 rpm (4 °C) for 10 min. Supernatants were collected, filtered through a 0.22 μm membrane, and analyzed by LC-MS. Chromatographic separation was performed on an ACQUITY UPLC HSS T3 column (1.8 μm, 2.1 × 100 mm) with gradient elution using mobile phase A (0.1% formic acid in water) and B (0.1% formic acid in acetonitrile). Mass spectrometry was conducted on a Thermo Orbitrap Exploris 120 (controlled by Xcalibur v4.7) with spectra acquired in positive and negative ion modes. Metabolomic raw data were processed in MS-DIAL (v4.9.221218) for peak extraction, alignment, filtering, and metabolite annotation, with identification via the PerSonalbio Next-Generation Metabolomics Database (PSNGM). Partial Least Squares-Discriminant Analysis (PLS-DA) was run via the plsda package, with differential metabolites (DEMs) identified by VIP ≥ 1 and P < 0.1. Heatmaps were generated using Pheatmap. KEGG pathway enrichment of DEMs was analyzed by Fisher’s exact test, with visualization via Pathview. All metabolomic analyses were conducted by PerSonalbio Biotechnology Co., Ltd. (Shanghai, China). Statistical analysis Statistical analyses were conducted using SPSS 27.0 software, in which the expression data of inflammatory cytokines and barrier protein-encoding genes was analyzed via the independent samples t-test, with all results presented as mean ± standard error (mean ± SEM). The microbial α-diversity indices were analyzed using the Kruskal-Wallis rank-sum test; meanwhile, combined correlation analyses between differential flora and phenotypic characteristics, as well as differential metabolites, were performed through Spearman’s rank correlation analysis. Results FMT alleviated the jejunal injury and restored intestinal barrier integrity in CpC-induced piglets HE staining demonstrated that FMT markedly improved jejunal mucosal morphology in the FC group, characterized by intact apical structure of villi without fusion or rupture, and an increased crypt count per unit area compared with the C group (Fig. 1A). Quantitative morphological analysis confirmed significantly greater jejunal villus height and shallower crypt depth in the FC group (P < 0.01, Fig. 1D, E). The content of serum pro-inflammatory cytokines TNF-α and IL-6 was significantly reduced, while the anti-inflammatory cytokine IL-10 was substantially elevated in the FC group (P < 0.01, Fig. 1F). However, the content of pro-inflammatory IL-1β showed no significant difference between the two groups (P > 0.05, Fig. 1F). PAS staining indicated a significant increase in the number of jejunal goblet cells in the FC group (P < 0.05, Fig. 1B). Immunohistochemistry revealed stronger positive expression and deeper staining of the tight junction proteins Claudin-1, Occludin and ZO-1 in the FC group (Fig. 1C), which was further quantified as extremely significant increases in histochemical scores (H-scores) (P < 0.01, Fig. 1G). Consistent with the protein-level findings, qRT-PCR analysis showed significant upregulation of Occludin and ZO-1 mRNA (P < 0.05, Fig. 1H), and an even more significant upregulation of Claudin-1 mRNA in jejunal tissues of the FC group (P < 0.01, Fig. 1H). Fig. 1Effects of FMT on intestinal tissue morphology, barrier function and inflammatory factors in CpC-infected piglets. A: H&E staining of jejunal tissue, scale bar = 100 μm; B: Periodic acid-Schiff (PAS) staining of jejunal tissue, scale bar = 200 μm; C: Immunohistochemistry (IHC) staining of jejunal tissue, scale bar = 100 μm; D: Jejunal villus height; E: Jejunal crypt depth; F: Serum inflammatory factor levels; G: Tight junction protein IHC scores; H: Tight junction protein gene expression levels; Different uppercase letters indicate significant differences (P < 0.05), while no letters indicate no significant differences (P > 0.05) Effects of FMT on intestinal tissue morphology, barrier function and inflammatory factors in CpC-infected piglets. A: H&E staining of jejunal tissue, scale bar = 100 μm; B: Periodic acid-Schiff (PAS) staining of jejunal tissue, scale bar = 200 μm; C: Immunohistochemistry (IHC) staining of jejunal tissue, scale bar = 100 μm; D: Jejunal villus height; E: Jejunal crypt depth; F: Serum inflammatory factor levels; G: Tight junction protein IHC scores; H: Tight junction protein gene expression levels; Different uppercase letters indicate significant differences (P < 0.05), while no letters indicate no significant differences (P > 0.05) FMT influences the composition of jejunal microbiota in CpC-infected piglets Following 16 S rRNA sequencing and quality control, 345,099 high-quality sequences remained for analysis. Rarefaction curves confirmed that the sequencing depth was sufficient to capture the community richness (Fig. 2A). α diversity analysis showed no significant differences in either community richness or diversity (P > 0.05, Fig. 2B). PCoA revealed a clear separation in the overall community structure, demonstrating compositional divergence (Fig. 2C). Bacterial composition analysis revealed that both groups were predominantly composed of Firmicutes_D and Actinobacteriota, which collectively accounted for over 60% of the total sequences. The C group was characterized by a notable proportion of Proteobacteria (20.6%), and a small unique fraction of Bacteroidota (1.1%). The FC group exhibited greater diversity within Firmicutes, including high abundances of Firmicutes_A, B, and C (Fig. 2D). Dominant genera shared between the two groups included Streptococcus, Lactobacillus, and Actinomyces, together comprising over 40% of the sequences. Unique signatures were evident: the C group was enriched with Saccharimonas (6.8%), Actinobacillus_C (4.6%), and Escherichia (3.9%), whereas the FC group was characterized by Rothia (10.3%), Veillonella_A (6.6%), and Pelistega (5.4%), alongside a high abundance of Ligilactobacillus (Fig. 2E). Fig. 2Effect of FMT on the jejunal microbiota of CpC-induced diarrheic piglets. A: Rarefaction curves of the C and FC group; B: Comparison of alpha diversity indices between groups; C: PCoA analysis of bacterial communities. D: Phylum-level taxonomic composition. E: Genus-level taxonomic composition Effect of FMT on the jejunal microbiota of CpC-induced diarrheic piglets. A: Rarefaction curves of the C and FC group; B: Comparison of alpha diversity indices between groups; C: PCoA analysis of bacterial communities. D: Phylum-level taxonomic composition. E: Genus-level taxonomic composition Differential analysis of jejunal microbiota revealed that the microbiota differences between C group and FC group mainly belonged to the phylum Firmicutes (Fig. 3A). Species-level differential analysis demonstrated that the relative abundances of Akkermansia muciniphila_D (genus Akkermansia) and Peptococcus niger (genus Peptococcus) were extremely significantly increased in the FC group (P < 0.01); the relative abundances of species including Proteocatella sphenisci (genus Proteocatella), Veillonella_A caviae (genus Veillonella_A), and Rothia nasimurium_A (genus Rothia) were significantly elevated (P < 0.05). Notably, while some bacterial taxa had numerically higher relative abundances in the C group, none of these differences reached statistical significance relative to the FC group. Random forest analysis screened core genera that made key contributions to intergroup differentiation (Fig. 3D). Top-ranked genera such as Bulleidia, Berryella, Fusobacterium_C, Lachnoanaerobaculum, Staphylococcus, and Rothia exhibited high abundance distributions in both groups; among them, Eubacterium_M and Atopobium were more abundant in FC Group, whereas Escherichia showed higher abundance in C Group. LEfSe analysis further identified intergroup-specific microbial biomarkers. A total of 18 key taxonomic units were screened based on linear discriminant analysis (LDA) scores. Specifically, FC Group formed a hierarchical specific biomarker clade composed of Firmicutes_C, class Peptococcia, order Peptococcales, family Peptococcaceae, genus Peptococcus, and species Peptococcus niger. Only Actinobacillus_B served as the specific biomarker for C Group (Fig. 3E). Functional prediction analysis of the microbiota in the two groups showed that the FC Group was significantly enriched in metabolic pathways including beta-Alanine metabolism, Tryptophan metabolism, and Lysine biosynthesis (Fig. 3F, P < 0.05); in contrast, the C Group were mainly enriched in disease-related pathways such as Vibrio cholerae infection and Bacterial chemotaxis (Fig. 3F, P < 0.05). Fig. 3Composition and function differences of jejunal microbiota between C group and FC group. A-C: Species difference analysis at the phylum, genus, and species levels. The abscissa sequentially displays the abundance unit conversion value (left), test method (middle), and corresponding P-value (right); the ordinate represents species names. D: Random forest analysis. The histogram shows the species importance scores; the heatmap illustrates the abundance distribution of each species across samples. Species are ranked in descending order of importance scores. E: Cladogram depicting the phylogenetic distribution. Circles from the inside to the outside sequentially represent taxonomic levels from domain to genus (or species), and circle size corresponds to relative abundance. F: LDA score distribution. Taxa with an LDA score > 3.0 exhibit significant differences in abundance between the two groups, and the bar length represents the LDA score. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); double asterisks (**) indicate highly significant differences (P < 0.01); no asterisk indicates no significant difference (P > 0.05) Composition and function differences of jejunal microbiota between C group and FC group. A-C: Species difference analysis at the phylum, genus, and species levels. The abscissa sequentially displays the abundance unit conversion value (left), test method (middle), and corresponding P-value (right); the ordinate represents species names. D: Random forest analysis. The histogram shows the species importance scores; the heatmap illustrates the abundance distribution of each species across samples. Species are ranked in descending order of importance scores. E: Cladogram depicting the phylogenetic distribution. Circles from the inside to the outside sequentially represent taxonomic levels from domain to genus (or species), and circle size corresponds to relative abundance. F: LDA score distribution. Taxa with an LDA score > 3.0 exhibit significant differences in abundance between the two groups, and the bar length represents the LDA score. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); double asterisks (**) indicate highly significant differences (P < 0.01); no asterisk indicates no significant difference (P > 0.05) FMT modulates the composition of jejunal microbial metabolites in CpC-infected piglets Analysis of the relative standard deviation (RSD) showed high data quality and instrument stability, with over 75% of feature peaks having RSD < 30% across all samples (Fig. 4A), meeting the requirements of subsequent analyses. Orthogonal partial least squares-discriminant analysis (OPLS-DA) revealed an obvious separation between C Group and FC Group in two-dimensional space (Fig. 4B). The samples of C Group clustered on the left, while those of FC Group clustered on the right, with no overlap in confidence intervals, indicating significant inter-group differences in overall metabolic profiles (P < 0.05). Metabolite identification showed that under both positive and negative ion detection modes, four core compound classes: lipids and lipid-like molecules, organic acids and derivatives, organoheterocyclic compounds, and benzenoids, collectively accounted for over 80% of detected metabolites (Fig. 4C). Fig. 4Metabolite Composition in C group and FC group under positive and negative ion modes. A: Quality control based on RSD analysis. The ordinate represents the proportion of peaks in QC samples, and abscissa represents RSD values. B: OPLS-DA score plot; C: Major metabolites classes under positive-and negative-ion modes Metabolite Composition in C group and FC group under positive and negative ion modes. A: Quality control based on RSD analysis. The ordinate represents the proportion of peaks in QC samples, and abscissa represents RSD values. B: OPLS-DA score plot; C: Major metabolites classes under positive-and negative-ion modes The analysis of differential metabolites (DEMs) revealed significant differences in metabolic profiles between the C and FC groups. A total of 150 DEMs were identified in this study, among which 67 were detected in positive ion mode (27 upregulated and 40 downregulated) and 83 in negative ion mode (21 upregulated and 62 downregulated) (Fig. 5A). KEGG pathway enrichment analysis indicated that these DEMs were mainly enriched in pathways including ABC transporters, insulin resistance, sphingolipid metabolism, diabetic cardiomyopathy, and the mTOR signaling pathway (Fig. 5B). The key DEMs among these were L(+)-Ornithine, D(-)-Fructose, L-Leucine, and Ceramide (d18:1/18:0), as presented in Fig. 5C. Fig. 5Differential metabolites between C group and FC group and their enriched pathways. A: Differentially expressed metabolites plot, where the ordinate represents the number of differentially expressed metabolites and the abscissa represents the groups; B: KEGG plot of differentially expressed metabolites enrichment, where the ordinate represents the pathway names and the abscissa represents -log10 (Pvalue); C: Key differential metabolites (DEMs) enriched in the top 20 metabolic pathways. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); no asterisk indicates no significant difference (P > 0.05) Differential metabolites between C group and FC group and their enriched pathways. A: Differentially expressed metabolites plot, where the ordinate represents the number of differentially expressed metabolites and the abscissa represents the groups; B: KEGG plot of differentially expressed metabolites enrichment, where the ordinate represents the pathway names and the abscissa represents -log10 (Pvalue); C: Key differential metabolites (DEMs) enriched in the top 20 metabolic pathways. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); no asterisk indicates no significant difference (P > 0.05) Bacteria, metabolites, and intestinal barrier synergistically mediate jejunal injury in CpC-induced piglets Our comprehensive correlation analysis revealed a significant and coherent network of associations among specific gut bacteria, key metabolites, intestinal barrier integrity, and inflammatory responses in CpC-induced jejunal injury. The genus Akkermansia had an extremely significant positive correlation (P < 0.01) with the expression levels of tight junction protein-encoding genes (Claudin-1, Occludin, ZO-1) and the content of the anti-inflammatory cytokine IL-10, whereas it exhibited an extremely significant negative correlation (P < 0.01) with the contents of the pro-inflammatory cytokines IL-6, TNF-α, and IL-1β. Consistent with this trend, the three genera Peptococcus, Pauljensenia, and Rothia all had a significant positive correlation (P < 0.05) with the expression levels of the aforementioned tight junction protein-encoding genes and the IL-10 content, and a significant negative correlation (P < 0.05) with the contents of the three pro-inflammatory cytokines IL-6, TNF-α, and IL-1β. Furthermore, the genera Proteocatella, F0422, and Veillonella_A displayed the same correlation trends with the aforementioned indicators as the abovementioned genera (Fig. 6A). Having clarified the associations between differential gut microbiota and intestinal barrier as well as inflammatory phenotypes, this study further performed a combined analysis of the differential metabolites between the two groups and those enriched in the top 20 metabolic pathways to explore the intrinsic links between gut microbiota and metabolic phenotypes. The results indicated that: the genera Akkermansia, Peptococcus, and Proteocatella all had a significant positive correlation (P < 0.05) with the differential metabolite Ceramide (d18:1/18:0); the genera Akkermansia and Rothia had a significant negative correlation (P < 0.05) with orotic acid and L-leucine; the genus Peptococcus had a significant negative correlation (P < 0.05) with PC (16:0/0:0), L-leucine, xanthosine, and L-ornithine; and the genus Pauljensenia had an extremely significant negative correlation (P < 0.01) with orotic acid (Fig. 6B). To verify the observed associations among differential genera, phenotypes, and metabolites, we selected the genera Akkermansia, Rothia, and Peptococcus—all of which showed significant correlations with both phenotypic and metabolic indicators, and further analyzed their representative species (Akkermansia muciniphila_D, Peptococcus niger, Rothia nasimurium_A) in relation to the same set of variables. The results confirmed that these species exhibited correlation patterns consistent with their respective genera (Fig. 6C, D). Taken together, these findings suggest that in CpC-induced jejunal injury in piglets, Akkermansia, Peptococcus, and Rothia may act synergistically to enhance intestinal barrier function and promote anti-inflammatory responses through modulating metabolites such as ceramide, orotic acid and L-leucine. This study thus elucidates a potential mechanistic axis involving microbiota-metabolite-intestinal barrier interactions in mediating intestinal injury. Fig. 6Integrated correlation analysis of differential bacterial, metabolites and phenotypes. A: Correlation between differential bacterial genera and phenotypic characteristics; B: Correlation between differential genera and metabolites; C: Correlation between differential bacterial species and phenotypic characteristics; D: Correlation between differential bacterial species and phenotypic characteristics. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); double asterisks (**) indicate highly significant differences (P < 0.01); no asterisk indicates no significant difference (P > 0.05) Integrated correlation analysis of differential bacterial, metabolites and phenotypes. A: Correlation between differential bacterial genera and phenotypic characteristics; B: Correlation between differential genera and metabolites; C: Correlation between differential bacterial species and phenotypic characteristics; D: Correlation between differential bacterial species and phenotypic characteristics. Asterisks (*) in the figure indicate statistically significant differences (P < 0.05); double asterisks (**) indicate highly significant differences (P < 0.01); no asterisk indicates no significant difference (P > 0.05) Discussion Intestinal villus atrophy and crypt deepening induced by CpC infection are hallmark features of mucosal barrier damage, which are associated with disrupted proliferation-differentiation homeostasis of intestinal stem cells (ISCs) [28]. Under physiological conditions, ISC activity relies on the precise regulation of the Wnt/β-catenin signaling pathway. This pathway ensures continuous epithelial regeneration by maintaining ISC self-renewal and differentiation [29, 30]. Notably, Akkermansia can exert therapeutic effects by regulating this pathway through degrading mucin to produce short-chain fatty acids; these metabolites activate the nuclear localization and transcriptional activity of β-catenin, thereby promoting the proliferation and self-renewal of ISCs [31]. Meanwhile, Lactobacillus stimulates ISC proliferation via NADPH oxidase 1 (Nox1)-dependent reactive oxygen species signaling [32], and Ligilactobacillus accelerates intestinal metabolism to promote ISC renewal [33]. In this study, the intestinal microbiota of piglets remodeled by fecal bacterial suspension from Hezuo pigs not only exhibited high relative abundances of Lactobacillus and Ligilactobacillus, but also had Akkermansia as a significantly dominant genus. This optimization of microbiota structure may synergistically activate the proliferation and differentiation mechanism of ISCs through the aforementioned multiple pathways, thereby exerting a repair effect at the morphological level. Specifically, the jejunal villus length of piglets in the FC group was significantly restored, and the crypt depth was also markedly improved. Compared with the jejunal histological parameters of DLY piglets of similar age without any treatment reported by Xu et al. (villus length: approximately 400–450 μm; crypt depth: approximately 150–200 μm), the results measured in this study also fell within this normal reference range [34]. The above findings indicate that fecal microbiota transplantation can effectively alleviate CPC-induced intestinal mucosal injury in piglets and promote the recovery of jejunal tissue structure to a level close to the normal physiological state. The intestinal physical barrier also depends on tight junctions, which are composed primarily of Claudin, Occludin, and the ZO protein families [35]. Reduced levels of these proteins increase intestinal permeability, allowing pathogen translocation and systemic inflammation [36, 37]. Here, piglets in the FC group exhibited stronger immunohistochemical staining for Claudin-1, Occludin, and ZO-1 proteins, along with significantly upregulated mRNA levels of Occludin, ZO-1, and Claudin-1. These findings confirmed that FMT promotes tight junction restoration. Metabolomic analysis further revealed enrichment of sphingolipid metabolites in the FC group, which are known to enhance claudin-1 expression and tighten junctional structure [38]. This cross-dimensional regulatory mechanism involving metabolic shifts from metabolism to gene expression provides evidence for the observed barrier repair. Regarding the chemical barrier, FMT-mediated crypt restoration created a favorable niche for ISC differentiation into goblet, absorptive, and endocrine cells [39]. PAS staining demonstrated that the number of goblet cells in the FC group was significantly higher than that in the C group. As the core executors of mucin synthesis and secretion, increased goblet cells directly enhance the mucus layer [40]. Enrichment of Akkermansia likely contributed to this process by directly promoting goblet cell proliferation. Furthermore, its mucus degradation activity can feed back to enhance mucin synthesis [41]. The thickened mucus layer, serving as a frontline chemical barrier, prevents pathogen invasion and shields epithelial cells [42, 43]. In summary, through the dual mechanism of improving epithelial permeability and enhancing the mucus layer, FMT concurrently fortified both the physical and chemical barriers, synergistically alleviating CpC-induced intestinal damage in piglets. In innate immunity, the balance of cytokines and chemokines critically shapes anti-pathogen responses [44]. Pro-inflammatory cytokines IL-6 and TNF-α participate in intestinal immune regulation by mediating defensive inflammation, but their overproduction causes tissue damage and exacerbates diarrhea-associated pathology [45]. In contrast, the anti-inflammatory cytokine IL-10 maintains immune homeostasis by suppressing excessive inflammation [46]. This study found that FMT bidirectionally regulated cytokine profiles, which effectively inhibited the pathological elevation of TNF-α and IL-6 while significantly increasing IL-10. This rebalance may be driven by microbial metabolites. Meanwhile, KEGG pathway enrichment analysis of metabolomic sequencing data showed that differential metabolites were predominantly enriched in pathways including ABC transporters, sphingolipid metabolism, mTOR signaling pathway, insulin resistance and amino acid metabolism. The core differential metabolites included L(+)-ornithine, D(-)-fructose, L-leucine and ceramide (d18:1/18:0). Among these, sphingolipid metabolism was the most significantly enriched lipid metabolic pathway for differential metabolites, and its core intermediate product ceramide (d18:1/18:0) is a key lipid molecule regulating intestinal homeostasis. Previous studies have shown that ceramide can maintain the structural integrity of the intestinal mucosa, negatively regulate inflammatory signaling pathways, and enhance intestinal epithelial cell membrane stability as well as gut barrier defense capacity [47]. Notably, the ceramide and sphingomyelin detected in this study were also found to be significantly altered in previous studies on ulcerative colitis, suggesting their potential as biomarkers for intestinal barrier dysfunction [48, 49]. Furthermore, the combined analysis of differential microbiota and metabolites revealed that ceramide content was significantly positively correlated with the abundances of core beneficial bacteria such as Akkermansia and Peptococcus. Similar correlations have also been reported in metabolic intestinal diseases, for example, Akkermansia muciniphila can participate in the regulation of intestinal inflammation by modulating metabolites such as gamma-aminobutyric acid and ceramide [50, 51].This result suggests that fecal microbiota transplantation may activate the sphingolipid metabolic pathway by remodeling the intestinal microbiota, thereby increasing ceramide content and exerting an intestinal protective effect. The ABC transporter family is involved in the transmembrane transport of various nutrients and metabolites. Its intestinal expression is regulated by the gut microbiota and is closely associated with the absorption and utilization of amino acids and lipids. Studies have shown that upregulation of the ABC transporter-related proteins Abcg5 and Abcg8 can alleviate colitis in mice [52]. Therefore, Hezuo pig-derived fecal microbiota transplantation may promote intestinal and systemic metabolic homeostasis through the coordinated regulation of amino acid metabolism and the ABC transporter signaling pathway. Several limitations still exist in the present study. First, no independent blank control group was included, and the histological recovery of the intestinal tissue was only indirectly assessed by comparison with normal reference ranges reported in the literature. Nevertheless, the significant differences observed between the intervention group and the model control group still effectively support the therapeutic effects of the transplantation. Second, due to ethical constraints and the exploratory nature of this study, the number of biological replicates per group was only four. Given the considerable heterogeneity among individuals, this limited sample size may affect statistical power. To control for individual variation, we strictly selected healthy piglets of the same litter and uniform body weight. These limitations do not affect the main design or conclusions of this study, and further validation with larger sample sizes will be conducted in future work. Conclusion This study demonstrates that FMT can significantly enrich beneficial intestinal bacteria such as Akkermansia, Rothia, and Peptococcus, and modulating the production of metabolites such as Ceramide (d18:1/18:0), orotic acid, and L-leucine in CpC-infected piglets. Through such microbiota-metabolite crosstalk, FMT synergistically enhances intestinal barrier function and promotes anti-inflammatory reactions, thereby alleviating CpC-induced jejunal damage. These findings provide a theoretical basis for the potential application of FMT in preventing and treating CpC-associated diarrhea in piglets.